Biotechnology and related specialities

A new year, a new Pharma Trends Outlook report! The 2025 Pharma Trends Outlook report examines key changes expected in the pharmaceutical industry for the coming year, particularly in regards to the supply chain.

Novavax has sold its Czech manufacturing facility to Novo Nordisk for $200 million, including the site’s 300 employees, in a move to cut costs and focus on vaccine development.

Sanofi completed the acquisition of the clinical-stage biotech company Inhibrx in late May 2024 after settling on a US$1.7 billion buyout. The acquisition brings with it a rare disease therapy to bollster Sanofi's pipeline. 

In this comprehensive downloadable report, hear from a range of experts in finance and investment in the pharma industry on what investment trends will be shaping the future of the industry, in Catalonia, and the wider world. 

Cromatic, the digital platform for outsourced life sciences research, has announced that it has received $5.3 million in funding in total from a range of investors. 

Infographic introducing the Biotech City in Greater Montreal in Canada, home to 120 life science companies. The infographic outlines more details on the Biotech City in terms of facilities and resources the area provides. 

To assist with the growth of the biotechnology industry and support newly emerging biotech companies, Thermo Fisher Scientific have made the move to be a founding sponsor of Momentum Labs in Alachua, FL, USA. 

China’s pharmaceutical industry is changing from formerly generics-focused into one that emphasizes innovation, spurred by shifting government policy and an aging population.

Researchers in South Korea have developed an electronic tattoo that automatically signals potential health issues. 

TFBS will use Univercells’ scale-X™ carbo mid-scale fixed-bed bioreactor to support GMP viral vector operations 

Companies that are further down the road to market are more attractive to investors than those in early development 

A US-based biotech is seeking damages for Pfizer’s use of a patented coronavirus 3CL protease inhibitor in its blockbuster drug Paxlovid